BBLG
Bone Biologics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.19M
P/E Ratio
—
EPS
$-1.16
Beta
0.53
52W High
$6.75
52W Low
$1.05
50-Day MA
$1.26
200-Day MA
$1.72
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Bone Biologics Corp
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein. The company is headquartered in Burlington, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | -824,964 |
| Operating Margin | 0.00% |
| Return on Equity | -70.20% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.00 |
| Price-to-Book | 0.47 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.80M |
| Float | $1.79M |
| % Insiders | 0.04% |
| % Institutions | 1.43% |
Historical Volatility
HV 10-Day
25.14%
HV 20-Day
30.45%
HV 30-Day
35.89%
HV 60-Day
43.45%
HV Rank
0.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($22.20 target)
More HEALTHCARE Stocks
Data last updated: 5/25/2026